Short answer
SOLENO THERAPEUTICS INC (SLNO) filed an 8-K current report with the SEC on March 16, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Bylaws amended Mar 16, 2026: tightened advance notice requirements for stockholder proposals and director nominations.
SOLENO THERAPEUTICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Bylaws amended Mar 16, 2026: tightened advance notice requirements for stockholder proposals and director nominations
- Added exclusive forum selection provision: limits where stockholders can bring certain legal claims against the company
- Updates reflect recent Delaware law changes and governance housekeeping: no shareholder vote required for board-adopted bylaw amendments
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SOLENO THERAPEUTICS INC 8-K filings
Get the next SLNO 8-K as it lands
Follow SLNO for push alerts, or ask the research agent what this filing means.